Tuesday, December 05, 2017 4:19:57 PM
This is fueled NOT by pending epi announcement, it is fueld by recent deregulation by fda that FITS ADMP PERFECTLY.
It allows their PROVEN injector to be used for many other purposes with STEEP:LY discounted COSTS to market and MUCH FASTER TIMES to market.
The opiod injector IND announcement is fueling this as it lays the groundwork for MANY MANY more specialty prefilled injector devices to be proposed and quickly approved under the new trump fda.
This is a goldmine
The ridiculous 2 year delay of the epi as fda complained about instructions training and human factors will NOT BE REPEATED when the APPROVED pen ids used for already APPROVED drugs in a PREFILLED injector as those PREVIOUS TRIALS AND TESTS WILL BE ACCEPTABLE for NDA application
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM